AFMD - Affimed N.V.'s (AFMD) CEO Adi Hoess On Q3 2020 Results - Quick Version Earnings Call Transcript
Affimed N.V. (AFMD) Q3 2020 Earnings Conference Call November 10, 2020 8:20 A.M. ET Company Participants Alexander Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Denise Mueller - Chief Business Officer Wolfgang Fischer - Chief Operating Officer Arndt Schottelius - Chief Scientific Officer Angus Smith - Chief Financial Officer Conference Call Participants Dilip Joseph - SVB Leerink Jim Birchenough - Wells Fargo Yale Jen - Laidlaw & Company Disclaimer: *NEW* We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. Presentation Operator [00:00:00] Good day, everyone, and thank you for standing by and welcome to our third quarter 2020 financial results and corporate update
For further details see:
Affimed N.V.'s (AFMD) CEO Adi Hoess On Q3 2020 Results - Quick Version Earnings Call Transcript